COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Behnood Bikdeli(Broad Institute), Gregory Y.H. Lip(Medical University of Białystok), Yutao Guo(Chinese General Hospital College of Nursing and Liberal Arts), Philippe Gabríel Steg(Mount Sinai Hospital), C. Michael Gibson(Baim Institute for Clinical Research), Jawed Fareed(Loyola University Chicago), Isaac Dreyfus(NewYork–Presbyterian Hospital), Claire McLintock(Auckland City Hospital), Mohammad Madjid(The University of Texas Health Science Center at Houston), Geoffrey D. Barnes(University of Michigan), Caroline Der‐Nigoghossian(NewYork–Presbyterian Hospital), Samuel Z. Goldhaber(Brigham and Women's Hospital), Ido Weinberg(Harvard University), Mary Cushman(University of Vermont), Alex C. Spyropoulos(Lenox Hill Hospital), Dominic P. Francese(Cardiovascular Research Foundation), Beverley J. Hunt(Guy's and St Thomas' NHS Foundation Trust), Sahil A. Parikh(NewYork–Presbyterian Hospital), Taylor Chuich(NewYork–Presbyterian Hospital), Yu Hu(Union Hospital), Anna Falanga(Ospedale Papa Giovanni XXIII), Stavros Konstantinides(Johannes Gutenberg University Mainz), Liang Tang(Union Hospital), Elissa Driggin(NewYork–Presbyterian Hospital), Gregg W. Stone(Cardiovascular Institute of the South), Gregory Piazza(Brigham and Women's Hospital), Stephan Rosenkranz(University of Cologne), Marc Carrier(University of Ottawa), Manuel Monréal(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Emmanuel J. Favaloro(The University of Sydney), Alfonso Tafur(NorthShore University HealthSystem), John Burton(University of Verona), I. Quéré(Centre Hospitalier Universitaire de Montpellier), Giuseppe Lippi(University of Verona), Elizabeth Wang(NewYork–Presbyterian Hospital), Mahesh V. Madhavan(NewYork–Presbyterian Hospital), Walter Ageno(University of Padua), Jeffrey I. Weitz(McMaster University Medical Centre), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), John W. Eikelboom(Population Health Research Institute), Evangelos Dimakakos(National and Kapodistrian University of Athens), Harlan M. Krumholz(Yale New Haven Hospital), David Jiménez(Universidad de Alcalá), Jay Giri(Hospital of the University of Pennsylvania), Joseph A. Caprini(NorthShore University HealthSystem), Joshua A. Beckman(Clinical Research Institute)
Cited by 2,937
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k